NCT00898820
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,244 public trials
1,186 recruiting studies
Carcinoma, Bronchogenic trial results
NCT01000480
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France
Completed
Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00085280
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
Completed
NSCLC Burden of Illness Study
NCT01772225
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00730925
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.41.32003 Boehringer Ingelheim Investigational Site Antwerp, Belgium
- 1200.41.32007 Boehringer Ingelheim Investigational Site Charleroi, Belgium
- 1200.41.32001 Boehringer Ingelheim Investigational Site Jette, Belgium
- 1200.41.32011 Boehringer Ingelheim Investigational Site Leuven, Belgium
NCT01106781
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Chongqing, Chongqing Municipality, China
- Research Site Guangzhou, Guangdong, China
- Research Site Wuhan, Hubei, China
NCT00984542
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +8 more
- Locations
-
- Hardin Memorial Hosptial Elizabethtown, Kentucky, United States
- The Jones Clinic - Germantown Germantown, Tennessee, United States
- Jackson-Madison County Hospital Jackson, Tennessee, United States
- Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States
Completed
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
NCT00247416
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Commonwealth Cancer Center Danville, Kentucky, United States
- Markey Cancer Center Lexington, Kentucky, United States
- Brown Cancer Center Louisville, Kentucky, United States
- St. Claire Regional Medical Center Morehead, Kentucky, United States
NCT00476216
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00538850
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
- Locations
-
- InSys Therapeutics, Incorporated Chandler, Arizona, United States